Search for: "Astellas Pharma US, Inc." Results 21 - 40 of 42
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
District Court for the District of Massachusetts has denied the motion to dismiss filed in the consolidated class action of In re Prograf Antitrust Litigation by the defendant, organ transplant drug manufacturer Astellas Pharma US, Inc. [read post]
20 Jul 2011, 4:04 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
29 Jun 2011, 3:34 am by Marie Louise
(Spicy IP) Indonesia’s pharma IP problems (IP Komodo) US: House Patent Reform Bill, HR 1249, still has the Administration’s and BIO’s support (BIOtechNow) (Patent Baristas) US: Supreme Court takes two more patent cases: Kappos v Hyatt; Caraco v Novo Nordisk (Patently-O) US: Patent Profile: Antisense Pharma secures patents for convection enhanced delivery (Patent Docs)   Products Adenoscan (Adenosine) – US: Patent… [read post]
10 Jun 2011, 6:22 am by Bexis
Astellas Pharma, US, Inc., 2007 WL 2137782 (E.D. [read post]
7 Nov 2010, 9:59 pm by Patent Docs
Inc. 1:10-cv-08274; filed November 2, 2010 in the Southern District of New York • Plaintiffs: Astellas US LLC; Astellas Pharma Inc. [read post]
5 Jan 2010, 10:56 am by Erin Miller
Opinion below (9th Circuit) Petition for certiorari Brief in opposition Petitioner's reply Docket: 09-335 Title: Astellas Pharma, Inc. v. [read post]
14 Oct 2009, 7:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]
5 Aug 2009, 5:35 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 May 2009, 5:24 am
: Omnicare, Inc v OHIM, Astellas Pharma GmbH (Class 46) CFI delivers judgment in case concerning ability of designer who assigns business and related IP to another company, to object when the company tries to register his name as a CTM: Elio Fiorucci v OHIM (IPKat) CFI: Good faith irrelevant when selling non-misleading sausages: Alberto Severi, in his own name and representing Cavazzuti e figli SpA, now known as Grandi Salumifici Italiani SpA v Regione Emilia-Romagna… [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California… [read post]
26 Feb 2009, 5:54 am
My fellow panellists were in-house counsel from Merck & Co., Inc., Pfizer Inc. and Astellas Pharma Canada Inc. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
1 Dec 2007, 9:00 am
: (Trademark Blog), Short paper on domain name monetization: (Trademark Blog),Comcast puts non-lawyer in charge of IP Strategy: (IAM),Are green technology IP rights owners about to become the new big pharma? [read post]
8 Nov 2007, 9:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalIP Think Tank top five's: (IP Think Tank),More on IP law in the virtual world: (VirtualLaw), Interesting times for the Citi brand: (IAM), Velcro has won control of the domain name velcro.biz: (OUT-LAW), The Economic Value of Patent 'Trolls': (IP Think Tank),Industry Trilateral group and the 'global patent application' project: (PatentDocs), Update on the BitTorrent war -… [read post]